Investing Profile

Dan Becker

InvestorVC
Managing Director at Access Biotechnology
accessbio-tech.comNew York, New York
Photo of Dan Becker, Managing Director at Access Biotechnology
Your Intro Paths to Dan Becker

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Dan Becker on

cb
Current Investing Position
Access Biotechnology Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
15

Dan Becker is on these Sector & Stage Rankings

Dan Becker's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
Hemab
Series COct 2025$160M
Series BFeb 2023$140M
$290M
Co-investors: Christine Borowski (Access Biotechnology), Uya Chuluunbaatar (Amzak Health Investors), Joseph Anderson (Soffinova Partners)
Day One Biopharmaceuticals
Post Ipo EquityJul 2024$180M
Series BFeb 2021$130M
Series AMay 2020$60M
$370M
Co-investors: Julie Grant (Canaan Partners)
GRO Biosciences
Series BJul 2024$60M
$66M
Co-investors: Russ Wilcox (Pillar VC), Ameena El-Bibany (Artis Ventures (AV))
Mariana Oncology
Series BSep 2023$180M
Series ADec 2021$75M
$250M
Co-investors: Geert-Jan Mulder (Forbion), Josh Resnick
Zurp
Pre SeedJan 2023$5M
$5M
Co-investors: Amy Wu (Menlo Ventures), Lenny Rachitsky (AirAngels), David Weisburd (10X Capital), Julia Lipton (Awesome People Ventures), Dhani Jones (QEY Capital), Pascal Unger (Darling Ventures), Nik Sharma, Baron Davis, Siqi Chen, Niklas Jansen
Matchpoint Therapeutics
Series AOct 2022$70M
$70M
Co-investors: Jason P. Hafler (Sanofi Ventures)
ACELYRIN
Series CSep 2022$300M
$550M
Co-investors: Richard Gaster (venBio)
Curie Therapeutics
Series ADec 2021$75M
$75M